New Medical Device Advertising Exemption in Thailand

Published on: November 30, 2020

Published by the Thai Ministry of Public Health on November 2, 2020, Gazette Volume 137, Section 2074, announces that medical devices sold to healthcare professionals are now exempt from some previous advertising requirements in Thailand. Under the new notification, medical device manufacturers do not need advertising approval anymore if they are selling products to healthcare professionals. These new regulations put Thailand in better alignment with other countries in the region and around the world, where pre-market advertising approval is not required. The shift in focus away from advertising regulation will be good for the medical device industry, removing a significant regulatory burden for manufacturers. 

This change is likely due to the upcoming implementation of new regulations expected in the near future and to better align with international marketing practices. It is important to note that this only applies to healthcare professionals and manufacturers selling directly to consumers will still need advertising approval before printing  in the Thai market. 

How to Maintain Compliance

Advertisers who are exempt from requesting permission to advertise will still need to submit a notification to the FDA as outlined in page 3 of the Gazette announcement. The submitted form will need to include information on the manufacturer, product, regulatory status, place and timing of the advertising, methods for limiting advertising to healthcare professionals only,  and a copy of the planned advertisement.

Lastly, the form also requires the manufacturer certify that the advertising restricted to healthcare professionals only and is not in violation of Section 59 of the Medical Device Act B.E. 2551 (2008) which states:

A medical device advertisement must:

  1. not be a false or exaggerated representation of the benefits, quality, quantity, standard, constituent or origin of the medical device;
  2. not represent any person’s endorsement or commendation of the medical device’s benefits;
  3. not offer a prize conditional upon the taking of chance by any means;
  4. not represent benefits in regard to the prevention, treatment, relief or cure of a disease or symptom of a disease of which advertisement is prohibited under a Notification published by the Minister;
  5. not contain a misleading statement on an essential substance in relation to the medical device.

Come Grow with Us

Contact Asia Actual if you’d like to learn how this regulation might affect your sales options in Thailand.

Asia Actual is a regulatory consulting company specializing in helping manufacturers grow their sales through independent license holding, direct fulfillment, and a variety of sales channel support services.

Blog Posts

Indonesia Freezes Government Purchases of 79 Categories of Imported Medical Devices

Per Presidential Regulation 12/2021, the Ministry of Health (MOH) is requiring products with a Domestic Component Level (TKDN) and Benefit Weigh Value (BMP) of 40% or more be purchased by government hospitals regardless of available foreign products.

Philippines Announces New PEMDL Essential Medical Device List

Notification AO 2021-0038 was released on June 11th, 2021 with the goal of creating a standardized system for determining and maintaining a database of essential medical devices, hereby known as the Philippine Essential Medical Device List (PEMDL). Additionally, the Medical Devices and Supplies Price Reference Index (MDSPRI) will also be established to provide more price transparency when it comes to medical devices in the Philippines.

Russia and Euro-Asian Neighbors Expected to Transition to EAEU Regulations in 2022

With the release of Decree 142, the Russian government has provided a roadmap for their transition to the new EAEU medical device regulations beginning January 1, 2022. After this date, all applications submitted must adhere to the EAEU rules which can vary significantly from the current Russian requirements.